IPOs
-
The firm’s underwriting performance is hard to piece together from the limited available data. -
The firm has zero pre-2020 reserves, no MGA relationships, and management with a strong record.
-
Sources said that while a late June-early July IPO is still on the table, a Q4 or early 2025 listing is expected.
-
The company went public Thursday at a price of $17 per share.
-
The underwriters will receive a 30-day option for an additional one million shares.
-
From here on out, insurers will likely have to rely on the strength of their individual stories.
-
Sources said the company has halted its Q2 listing and will reassess the market next year.
-
The carrier will reassess the market in the fourth quarter, or early in 2025.
-
The filing comes four months after Insurance Insider US revealed Bowhead’s intentions to launch an IPO this year.
-
Challenges include integration, delevering, winning staff over and building a compelling equity story.
-
Sources said preparations for a 2024 IPO were halted, but work could resume later this year.
-
Sources said Stone Point and CD&R will each have stakes of around 35%.
Related
-
Aspen files F-1 with SEC confirming 2025 IPO optionality
December 11, 2024 -
The jammed PE conveyor belt: Broking’s $200bn+ of trapped capital
December 11, 2024 -
Aspen revs up IPO preparations again to give Q1 optionality
October 22, 2024 -
Accelerant rekindles IPO work with Q1 2025 launch target
September 23, 2024 -
Core Specialty sets wheels in motion on New York IPO
August 29, 2024